Association of an interleukin-8 promoter polymorphism with esophageal squamous cell carcinoma in the Taihang mountain region

Chinese Journal of Clinical Oncology

Volumn 35, Issue 10, 2008, Pages 591-595

  Zhang, Liwei ^a   Du, Chaoqun ^a   Niu, Weiwei ^a   Yu, Weifang ^a   Ai, Jun ^a   Shen, Yuxia ^a   Wang, Slumping ^a   Wang, Shijie ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Genetic polymorphism; High incidence region; Interleukin 8

Indexed keywords

INTERLEUKIN 8;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; UPPER GASTROINTESTINAL TRACT;

EID: 77951665967     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families [J]. Thorax, 2000, 55(12):1023-1027.
2. Lee WP, Tai DI, Lan KH, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population [J]. Clin Cancer Res, 2005, 11(18):6431-6441.
3. Landi S, Moreno V, Gioia-Patricola L, et al. Association of common polymorphisms in inflammatory genes interleukin (IL) 6, EL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer [J]. Cancer Res, 2003, 63(13):3560-3566.
4. Vairaktaris E, Yapijakis C, Serefoglou Z, et al. The interleukin -8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma [J]. Eur J Surg Oncol, 2007, 33(4):504-507. (Pubitemid 46620664)
5. Savage SA, Abnet CC, Mark SD, et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma [J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(12):2251-2257.
6. Yang HP, Woodson K, Taylor PR, et al. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial [J]. Eur J Cancer Prev, 2006, 15(3):249-253. (Pubitemid 43791771)
7. Leibovici D, Grossman HB, Dinney CP, et al. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival [J]. J Clin Oncol, 2005, 23(24): 5746-5756. (Pubitemid 46300170)
8. Campa D, Hung RJ, Mates D, et al. Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk [J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(10):2457-2458. (Pubitemid 41437853)
9. Campa D, Zienolddiny S, Maggini V, et al. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer [J]. Carcinogenesis, 2004, 25(2):229-235. (Pubitemid 38239806)